Inventor profile of:

Andreas Huth

City:

Berlin

Country:

Germany

Published Applications:

28

Last publication date:

2011-05-26

Top Assignees for applications by Andreas Huth

The entities that hold a legal rights for patent applications filed by inventor Huth Andreas:

Recent patent applications by Huth Andreas

Andreas Huth from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-05-26
US20110124680A1
Chemistry; metallurgy

NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS

#2 | 2011-03-24
US20110071165A1
Chemistry; metallurgy

Aza- and polyazanthranyl amides and their use as medicaments

#3 | 2011-03-03
US20110052492A1
Human necessities

Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy

#4 | 2011-02-03
US20110027179A1
Human necessities

Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy

#5 | 2011-01-13
US20110009447A1
Chemistry; metallurgy

Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis

#6 | 2009-01-08
US20090012090A1
Human necessities

Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy

#7 | 2008-09-30
US10476761
-

Cyanoanthranilamide derivatives and the use thereof as medicaments

#8 | 2007-06-14
US20070135489A1
Chemistry; metallurgy

Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones

#9 | 2007-01-18
US20070015794A1
Chemistry; metallurgy

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

#10 | 2006-12-21
US20060287339A1
Chemistry; metallurgy

Aza- and polyazanthranyl amides and their use as medicaments

#11 | 2006-12-12
US10631018
-

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

#12 | 2006-11-23
US20060264425A1
Chemistry; metallurgy

Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

#13 | 2006-10-17
US9831506
-

Anthranilic acid amides and the use thereof as medicaments

#14 | 2006-07-27
US20060167030A1
Chemistry; metallurgy

Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof

#15 | 2006-07-25
US10275480
-

Ortho-substituted anthranilic acid amides and their use as medicaments

#16 | 2006-07-20
US20060160861A1
Chemistry; metallurgy

Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

#17 | 2006-06-01
US20060116380A1
Chemistry; metallurgy

Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

#18 | 2006-04-06
US20060074112A1
Human necessities

N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors

#19 | 2006-03-14
US10275479
-

Anthranyl amides and their use as medicaments

#20 | 2006-02-21
US10828951
-

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

#21 | 2006-01-19
US20060014747A1
Chemistry; metallurgy

Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents

#22 | 2005-11-24
US20050261343A1
Chemistry; metallurgy

Anthranilamides and their use as pharmaceutical agents

#23 | 2005-09-22
US20050207972A1
Human necessities

Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy

#24 | 2005-04-12
US10180289
-

VEGF receptor tyrosine kinase inhibitors

#25 | 2005-03-10
US20050054692A1
Chemistry; metallurgy

Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors

#26 | 2005-03-10
US20050054654A1
Chemistry; metallurgy

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

#27 | 2005-03-03
US20050049281A1
Chemistry; metallurgy

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones

#28 | 2005-02-10
US20050032816A1
Chemistry; metallurgy

N-oxide anthranylamide derivatives and their use as medicaments

InventorID:

3338299 ⎘